OCT 15, 2016 5:56 AM PDT

Brain Tumors: How Surgeons are Operating on the Inoperable

WRITTEN BY: Xuan Pham
Glioblastomas are notorious for being inoperable. That’s why when scientists developed a laser method to “cook” the tumor from the inside, they thought it was game-over for the malignant cancer. However, doctors soon discovered other problems – the tumor became swollen and endangered patients in other ways. Now, a combination technique may finally make it possible to effectively treat and remove the cancer.
 
Dubbed as the “octopus tumor,” GBMs are characterized with malignant glial cells forming vast networks of tendrils throughout the brain. This makes it nearly impossible to surgically remove all the cancerous tissues. As such, this brain cancer can evade even the most aggressive surgeries, chemotherapies, and radiotherapies, leaving patients with a five-year survival rate of less than 10 percent.
 
In 2013, Andrew Sloan and his colleagues pioneered a technique to treat the “inoperable” tumor. Since it would be difficult to remove it with conventional scalpels, Sloan and his team thought to kill the tumor by heating it up from the inside. They team developed a technique known as laser interstitial thermotherapy (LITT), which targets the laser to the tumor via a small hole in the scalp.
 
While LITT was successful at attacking the tumor, doctors soon found that the treatment led to swelling. This was especially dangerous for large tumors, where the deep swelling could seriously jeopardize a patient’s health.
 
So the surgeons had no choice but to operate on the inoperable. But in the course of this procedure, Dr. Sloan made a starling realization: the swollen, cooked tumor was mushy instead dense, and clean instead of bloody – the heat had apparently cauterized the tumor’s blood supply. This state of the tumor was amenable to being “sucked out” through a small hole in the skull, a craniotomy.
 

"I am very excited by the results of this study. This procedure is a new option for patients with these large malignant tumors," said Andrew Sloan, surgeon at the University Hospitals Case Medical Center, and lead author of the new study. "We have seen similar results and overall survival compared to LITT procedures performed in patients with smaller lesions and with lower risk."
 
The team has since performed this combination technique on 10 patients with extremely aggressive and intractable brain tumors, with promising results. Of the 10 patients, 6 remain alive with a median progression-free survival of 280 days, and a median overall survival of 482 days.
 
"We feel with further studies, LITT will continue to develop into a safer, more user-friendly technique that may help remove more of these deadly tumors than surgery alone can accomplish," said Sloan.

Additional sources: MNT
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
NOV 01, 2019
Clinical & Molecular DX
NOV 01, 2019
myTAIHEART Blood Test and Biopsy of Heart Transplant Recipients
Transplant rejection is a process where the immune system of the patient consider the donor's organ as foreign and rejects them. This is because t...
NOV 05, 2019
Clinical & Molecular DX
NOV 05, 2019
Meningitis and Encephalitis: Testing & Diagnosis Strategies for Effective Treatment
Meningitis is an inflammation of the membranes surrounding the brain (meninges) and spinal cord. Encephalitis, on the other hand, refers to inflammation of...
NOV 07, 2019
Neuroscience
NOV 07, 2019
Reading, Hearing Language Connects Meaning to Same Region in the Brain
Scientists at the University of California Berkeley used improved functional MRI resolution to show that similar neural circuits in the same regions of the...
NOV 26, 2019
Cannabis Sciences
NOV 26, 2019
Cannabis Provides Relief from Headache and Migraine Pain
Innovative technology allowed researchers to conduct the first-ever study of cannabis use for the treatment of headache and migraine pain in real-time. Wit...
DEC 05, 2019
Clinical & Molecular DX
DEC 05, 2019
Catching drug-resistant HIV mutants with next generation sequencing
Human immunodeficiency virus (HIV)-positive individuals are treated with antiretroviral therapies to reduce the amount of circulating virus, restore their...
FEB 19, 2020
Clinical & Molecular DX
FEB 19, 2020
Forget complicated scans - ovarian cancer can be detected in the blood
Results from clinical trials performed in Melbourne, Australia have revealed the diagnostic potential of a new test for ovarian cancer. Instead of using co...
Loading Comments...